Exposure to sugar rationing in the first 1000 days of life protected against chronic disease.
Level 3 - non-randomized controlled study
Quasi-experimental event study / natural experiment cohort study
PubMed 39480913 · doi:10.1126/science.adn5421
What was done
Researchers leveraged a quasi-experimental natural experiment created by the end of United Kingdom sugar rationing in September 1953, after which sugar consumption approximately doubled. Using an event study design with UK Biobank data, they compared health outcomes in adults conceived just before versus just after rationing ended to evaluate the impact of sugar restriction during the first 1000 days after conception on type 2 diabetes and hypertension.
What was found
Early-life sugar rationing was associated with an approximate 35% reduction in type 2 diabetes risk (delaying onset by 4 years) and an approximate 20% reduction in hypertension risk (delaying onset by 2 years). In utero exposure accounted for about one-third of this risk reduction, with protective effects increasing with postnatal restriction, especially after 6 months of age.
Why it matters
This study provides real-world, quasi-experimental evidence that restricting dietary sugar during conception, gestation, and infancy provides long-term protection against major adult cardiometabolic diseases.
Limits
The abstract does not report the exact sample size. The design relies on population-level policy timing as a proxy rather than direct individual measurements of maternal or infant sugar intake. Contemporaneous post-war economic or dietary changes around the time of de-rationing could also act as potential confounders.